BLACKROCK SMALLER COMPANIES TRUST PLC
All information is at 30 November 2014 and unaudited.
Performance at month end is calculated on a capital only basis
One Three One Three Five
Month Months Year Years Years
Net asset value* 2.1% -3.9% -1.1% 66.6% 146.6%
Share price* -2.1% -4.4% -8.7% 80.4% 169.4%
Numis ex Inv Companies + AIM 0.4% -5.2% -4.9% 38.8% 58.3%
*performance calculations based on a capital only NAV with debt at par, without
income reinvested. Share price performance calculations exclude income
reinvestment.
Sources: BlackRock and Datastream
At month end
Net asset value Capital only (debt at par value): 880.10p
Net asset value Capital only (debt at fair value): 872.66p
Net asset value incl. Income (debt at par value)**: 888.27p
Net asset value incl. Income (debt at fair value)**: 880.83p
Share price: 765.00p
Discount to Cum Income NAV (debt at par value): 13.9%
Discount to Cum Income NAV (debt at fair value): 13.2%
Net yield^^^: 1.7%
Gross assets^: £465.2m
Gearing range as a % of net assets: 0-15%
Net gearing including income (debt at par): 9.5%
2014 Ongoing charges ratio^^: 0.7%
2014 Ongoing charges ratio (including
performancefees): 1.0%
Ordinary shares in issue#: 47,879,792
**includes net revenue of 8.17p
^includes current year revenue
^^ As reported in the Annual Financial Report for the year ended
28 February 2014, the ongoing charges ratio is calculated as a percentage of
net assets and using operating expenses, excluding performance fees, finance
costs and taxation.
^^^Yield calculations are based on dividends announced in the last 12 months as
at the date of release of this announcement, and comprise the final dividend of
7.40 pence per share (announced on 25 April 2014 and gone ex-dividend on 14 May
2014) and the interim dividend of 5.50 pence per share, (announced on 24
October 2014, gone ex-dividend on 6 November 2014).
#excludes 2,113,731 shares held in treasury.
Sector Weightings % of portfolio
Industrials 26.7
Consumer Services 18.8
Financials 17.6
Technology 9.5
Basic Materials 8.6
Health Care 7.8
Consumer Goods 7.3
Oil & Gas 2.1
Telecommunications 1.6
-----
Total 100.0
=====
Ten Largest Equity Investments
Company % of portfolio
Polar Capital Holdings 1.8
Workspace Group 1.8
Avon Rubber 1.8
Senior Engineering 1.7
Tyman 1.6
Bodycote 1.6
Lookers 1.5
Headlam Group 1.5
Hutchison China Meditech 1.5
Elementis 1.5
Commenting on the markets, Mike Prentis, representing the Investment Manager
noted:
During November the Company's NAV per share rose by 2.1% on a capital only
basis whilst the benchmark index rose by 0.4%; the FTSE 100 Index rose by 2.7%.
Portfolio outperformance was helped by a number of stocks including Hutchison
China Meditech, on further consideration of good interims and director's share
buying; Topps Tiles, on final results showing earnings per share growth of
21.9%; and Fevertree Drinks, on a successful IPO. Our holdings in Quintain
Estates and Avon Rubber also performed well and we had good meetings with the
management of both companies following results.
Detracting from this was the continuing drag from bid approaches to companies
in our benchmark but not in our portfolio: in November not owning Songbird
Estates was our largest detractor from relative contribution.
We decided to take some profit in a few of our AIM holdings, including some of
our holdings in oil producers as the oil price fell sharply. We took part in a
few IPOs including Fevertree Drinks, which develops and sells high quality soft
drinks including tonic water; and Virgin Money. We added a few other small
holdings in companies that have recently impressed us on meeting.
11 December 2014
ENDS
Latest information is available by typing www.blackrock.co.uk/brsc on the
internet, "BLRKINDEX" on Reuters, "BLRK" on Bloomberg or "8800" on Topic 3 (ICV
terminal). Neither the contents of the Manager's website nor the contents of
any website accessible from hyperlinks on the Manager's website (or any other
website) is incorporated into, or forms part of, this announcement.
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.